Therapeutic Hemp Medical Access Act of 2015

Summary

Therapeutic Hemp Medical Access Act of 2015 Amends the Controlled Substances Act to exclude cannabidiol and cannabidiol-rich plants: (1) from the definition of "marihuana," and (2) from treatment as a controlled substance under such Act. Defines: (1) "cannabidiol-rich plant" to mean the plant Cannabis sativa L. and any part of such plant with a tetrahydrocannabinol concentration of not more than 0.3% on a dry weight basis; (2) "cannabidiol" to mean the substance cannabidiol, as derived from a cannabidiol-rich plant; and (3) "tetrahydrocannabinol concentration" to mean the percent of the delta-9 tetrahydrocannabinol content per dry weight of any part of the plant Cannabis sativa L. or per volume of weight of marihuana product, or the combined percent of the delta-9 tetrahydrocannabinol and tetrahydrocannabinolic acid in any part of the plant Cannabis sativa L., regardless of moisture content. Declares that nothing in this Act shall be construed to restrict any activities related to the use, production, or distribution of marihuana in a state in which such activities are legal under state law.

This text is taken from the official record. PoliticalRepo does not editorialize.

Timeline

No timeline events have been ingested for this record yet.

Votes

No vote records are attached yet.

Versions

No version snapshots stored. Document URLs remain at the source.

Documents

3 official files

• Introduced in Senate (text)

  Introduced in Senate · EN · 13 May 2015

  ViewDownloadOpen at official source

• Introduced in Senate (PDF)

  Introduced in Senate · EN · 13 May 2015

  ViewDownloadOpen at official source

• Introduced in Senate

  summary · EN · 13 May 2015

  Open at official source

Sponsors

No sponsors or actors listed by the source.

Related records

No cross-record relationships stored yet.